Mirae Asset Securities
VC Fund
Nyack, United States
Mirae Asset Securities is a VC fund in Nyack focused on Software and Artificial Intelligence. Mirae Asset Securities specializes in offering Prime Brokerage, Securities Financing, Agency Execution, and Correspondent Clearing services. They provide comprehensive financial services, including asset management, wealth management, investment banking, and life insurance.
- Total investments:
- 17
- Last investment:
- Lead investor:
- 18%
Last updated:
For AI agents: llms.txt
Industries Mirae Asset Securities invests in
Stages Mirae Asset Securities invests in
Countries Mirae Asset Securities invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $2.7M–$12M
- Series C
- $15M–$19M
Investment Focus
Industry
- Software 7 (41%)
- Artificial Intelligence 6 (35%)
- Health Care 3 (18%)
- Information Technology 3 (18%)
- FinTech 2 (12%)
Stage
- Series A 4 (24%)
- Venture - Series Unknown 4 (24%)
- Series C 3 (18%)
- Funding Round 2 (12%)
- Series B 1 (6%)
Country
- South Korea 14 (82%)
- United States 2 (12%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Brandon Angus
Chief Technology Officer
|
Chief Technology Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| I Hate Flying Bugs is an education platform that has developed AI-based teaching and training services. The company offers personalized learning management systems to help students learn. The company aims to close the education gap with equal opportunities for high-quality education. It operates learning management platforms Mildang PT and SchoolPT. | $14.7M / Series C / Oct 27, 2025 | ||
| Banksalad is a fintech company that develops financial applications. | $366.7K / Venture - Series Unknown / Jul 03, 2025 | ||
| VESSL AI enables machine learning teams to develop state-of-the-art models at scale without the complex and repetitive process of setting up pipelines and infrastructures.In addition to a centralized dashboard and workflow management, VESSL AI offers enterprise-grade infrastructure equipped with automated resource provisioning, and powerfultraining modes with automated hyperparameter optimization and multi-node distributed training. | $12.2M / Series A / Oct 07, 2024 | ||
| Medi Whale seeks to achieve sustainable healthcare where every eye can truly be the window to one’s health with our world's first-of-its-kind 1-stop AI screening platform solution for cardiovascular, renal, metabolic risk assessment, and eye disease diagnosis. Our AI Platform was developed through several clinical collaborations (Korea,Singapore, India, UK, and other European datasets) using structured longitudinal event-based datasets for the development of our retinal biomarker engines. RetiCVD® (cardiovascular disease risk assessment): Developed using coronary artery calcium (CAC) score, CAC is recognized as the gold standard for precise CVD risk calculation. Our CVD engine predicts the presence of CAC and provides a stratified probabilistic risk based on US ASCVD and EU SCORE guidelines.RetiCKD® (chronic kidney disease risk assessment): Developed using eGFR and full lab panel, our CKD engine has been demonstrated to achieve better predictive capability as compared to eGFR or full panel analysis.RetiEYE®: Referable Eye Disease engine detects and flags common aging-related eye modalities such as diabetic retinopathy, age-related macular degeneration, glaucoma, and cataract at its referable disease state.Medi Whale retinal-based systemic biomarkers have been clinically demonstrated to be non-inferior to current gold standards and are recognized by clinical and scientific communities with two Lancet Digital Health publications. | $12M / Series A / Sep 26, 2024 | ||
| Nota AI is a tech startup with a focus on optimizing AI models with NetsPresso, the proprietary hardware-aware AI optimization platform, and enabling a diverse range of AI solutions, including intelligent transportation systems and low-powered driver monitoring systems. | $18.7M / Series C / Jun 18, 2024 | ||
| Clodot is an information technology company. | $8.4M / Venture - Series Unknown / Dec 19, 2023 | ||
| NPCore established in 2008 to develop specialized malware detection and response solutions in the anti-virus centric security market. Since the establishment, NPCore has launched multiple products and possessed intellectual properties through continuous research and development, grown as a leader with a leading technology in the market by afierce competition with the world class security professional companies, and will launch network and end-point security products and NPU-based high performance products based on accumulated technical know-hows and extend a product line-ups by investing more on the business infrastructure. NPCore will move to become a global security company that represents Korea. | $6.2M / Venture - Series Unknown / Nov 28, 2023 | ||
| MEZOO is a medical device manufacturing company. | $13.8M / Series B / Nov 07, 2023 | ||
| Neurophet is a medical technology enterprise that focuses on neuro-engineering and brain health. The company develops software programs that utilize artificial intelligence for the analysis of medical brain images. The firm creates simulation tools specifically for medical researchers and doctors who perform non-invasive electrical brainstimulation procedures. These applications allow medical professionals to generate three-dimensional models of individual human brains directly from magnetic resonance imaging data. | $15.3M / Series C / Nov 07, 2023 | ||
| Dot Mill is a media and entertainment technology company that designs, produces, and operates digital theme parks, interactive exhibitions, media attractions, and XR-based experiences. Dotmill combines storytelling with projection mapping, holograms, interactive media, digital twins, and extended reality technologies to create highly immersivevisitor experiences. | $11.7M / Sep 01, 2023 | ||
| See all 17 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Mirae Asset Securities invest in?
Mirae Asset Securities invests primarily in Software, Artificial Intelligence and Health Care startups, most often at Series A and Venture - Series Unknown stage. Most of the 17 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Mirae Asset Securities's check size?
Mirae Asset Securities typically joins rounds of $2.7M–$12M at Series A and $15M–$19M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Mirae Asset Securities participates in.
How do I contact Mirae Asset Securities?
Public channels for Mirae Asset Securities include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Mirae Asset Securities?
The team at Mirae Asset Securities includes Brandon Angus (Chief Technology Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
